4-traders.com, stock quotes, stock exchange, market price, stock market advice, technical analysis, stock chart analysis, Company News

Member access

Equities
Indexes
- Europe
  
  FTSE 100
  DAX
  CAC 40
  BEL 20
  ATHEX COMP
  RUSLAND RTS
  SMI
  IBEX 35
  MILANO MIB
  AEX
  PSI 20
  POLAND WIG
- Asia, Pacific
  
  NIKKEI 225
  SHANGHAI COMP
  HANG SENG
  KOSPI COMP
  SENSEX
  TAIWAN TWSE
  THAILAND 50
  SYDNEY ASX
- Middle East
  
  EGX 30
  TELAVIV 25
Commodities
- Metals
  
  GOLD
  SILVER
  PLATINUM
  PALLADIUM
  ALUMINIUM
  COPPER
  LEAD
  TIN
  ZINC
- Agriculture
  
  COFFEE
  SUGAR
  CORN
  COCOA
  COTTOM
  WHEAT
  PALM IOL
  SOYBEANS
Currencies
News
- Companies
  
  All News
  Press Releases
  Events
  Corporate actions
- Economy & Forex
  
  All News
  Currencies / Forex
  Economic Events
  Press releases
Analysis
Top & Flop
Market Screener
- Technical Analysis
  
  Oversold stocks
  Overbought stocks
  Close to resistances
  Close to supports
  Accumulation phase
  Most volatile stocks
- Fundamentals
  
  Top Investor Rating
  Top Trading Rating
  Top Consensus
  Growth stocks
  Yield stocks
  Low valuations
Calendar
- Finance Calendar
- Economic Calendar

4-Traders Homepage > Shares > Toronto Stock Exchange > Cardiome Pharma Corp. CA14159U3010

CARDIOME PHARMA CORP.

0

End-of-day quote Toronto Stock Exchange - 05/21
2.06	CAD		-9.25%

05/09

CARDIOME PHARMA CORP.: Cardiome To Hold First Quarter 2013 Financial Resul..

05/02

CARDIOME PHARMA CORP.: Cardiome Accepts The Transfer Of Sponsorship Of U.S..

04/25

CARDIOME PHARMA CORP.: Cardiome Announces Worldwide Sales And Marketing Of..

Forums > Cardiome Pharma Corp. Forum

- no discussion -

Advertisement

Income Statement Evolution

Cardiome Pharma Corp. : Income Statement Evolution

More Financials

Chart CARDIOME PHARMA CORP.

Duration : Period :

Cardiome Pharma Corp. Technical Analysis Chart | CA14159U3010 | 4-Traders

Full-screen chart

Dynamic quotes | OFF

My Watchlist|My Portfolio

4-traders.com :

About :

Copyright © 2013 Surperformance. All rights reserved.